DIABETES MELLITUS AFTER RENAL TRANSPLANTATION: As Deleterious as Non-Transplant-Associated Diabetes?1


    loading  Checking for direct PDF access through Ovid

Abstract

Background.Despite use of lower doses of corticosteroid hormones after renal allotransplantation in the era of cyclosporine and tacrolimus, posttransplant diabetes mellitus remains a common clinical problem.Methods.We prospectively investigated the effect of posttransplant diabetes on long-term (mean follow-up, 9.3±1.5 years) graft and patient survival in the 11.8% of our renal transplant population (n=40) who developed diabetes after kidney transplantation, and we compared outcome in 38 randomly chosen nondiabetic control patients who had received transplants concurrently.Results.Twelve-year graft survival in diabetic patients was 48%, compared with 70% in control patients (P=0.04), and Cox's regression analysis revealed diabetes to be a significant predictor of graft loss (P=0.04, relative risk=3.72) independent of age, sex, and race. Renal function at 5 years as assessed by serum creatinine level was inferior in diabetic patients compared to control patients (2.9±2.6 vs. 2.0±0.07 mg/dl, P=0.05). Two diabetic patient who experienced graft loss had a clinical course and histological features consistent with diabetic nephropathy; other diabetes-related morbidity in patients with posttransplant diabetes included ketoacidosis, hyperosmolar coma or precoma, and sensorimotor peripheral neuropathy. Patient survival at 12 years was similar in diabetic and control patients (71% vs. 74%).Conclusions.Posttransplant diabetes mellitus is associated with impaired long-term renal allograft survival and function, complications similar to those in non-transplant-associated diabetes may occur in posttransplant diabetes, and, hence, as in non-transplant-associated diabetes, tight glycemic control may also be warranted in patients with posttransplant diabetes.

    loading  Loading Related Articles